NRC

Business Context and Reporting Period

Company: National Research Corporation (NRC Health)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and six months ended June 30, 2008
Business Overview: NRC Health provides survey-based performance measurement, analysis, tracking, and governance education services to the healthcare industry in the U.S. and Canada. Key offerings include the Healthcare Market Guide and a new subscription-based data collection service called "TICKER."

Key Financial Metrics

Note: Working capital is calculated as Current Assets ($12,281,784) minus Current Liabilities ($20,615,511).

Material Changes vs. Prior Period

• Revenue Growth: Revenue for the six months ended June 30, 2008, increased 5.0% to $25.4 million compared to $24.2 million in the prior year period, driven by increased scope of work from existing clients and new client additions. Quarterly revenue remained flat at $11.9 million.
• Profitability: Net income for the six-month period increased 10.8% to $3.58 million. Operating margins improved to 23.1% for the six-month period (up from 22.5% in 2007) due to a higher mix of higher-margin products.
• Liquidity & Debt: Cash and cash equivalents decreased by $2.0 million to $1.3 million. Total debt increased to $3.3 million, all classified as current liabilities. This increase was primarily due to utilizing a revolving credit facility to fund stock repurchases.
• Working Capital Deficiency: The company reported a working capital deficiency of $8.3 million, a significant increase from a $415,000 deficiency in the prior year. This was driven by a $2.9 million increase in "billings in excess of revenue earned" (deferred revenue) and stock repurchases.
• Share Repurchases: The company spent $6.6 million on treasury stock purchases during the six-month period, significantly reducing shareholders' equity.

Guidance, Outlook, and Risks

• New Product Launch: In May 2008, the company launched "TICKER," a subscription-based service. Approximately $1.2 million of revenue was deferred in Q2 2008 and will be recognized over 12 months starting in Q3 2008.
• Capital Expenditures: The company budgeted approximately $1.9 million for capital expenditures in 2008, primarily for hardware, software, and production equipment. $1.3 million was spent in the first six months.
• Debt Maturity: The company intends to repay its $3.3 million debt within one year. Management expects cash flows from operations to be sufficient to repay the revolving line of credit before its expiration in July 2009.
• Risk Factors: No material changes to risk factors were reported since the 2007 Annual Report. Key risks include reliance on cash flows to service debt and the impact of foreign currency translation (the company has a Canadian subsidiary).
• Management Commentary: Management believes the company has adequate capital resources to meet projected needs. The increase in deferred revenue is attributed to the timing of initial billings on new and renewal contracts.

Investor Verification Checklist

• Deferred Revenue Recognition: Verify the timing and amount of revenue recognition for the new "TICKER" product and the $1.2 million deferred in Q2.
• Debt Covenants: Confirm continued compliance with financial ratio covenants in the credit facility, given the working capital deficiency.
• Stock Repurchase Impact: Assess the long-term impact of the $6.6 million share buyback on liquidity and future capital flexibility.
• Client Concentration: Review the 10-K for details on client concentration, as revenue growth is attributed to existing and new clients in the healthcare sector.
• Foreign Currency Exposure: Monitor the impact of currency translation on the Canadian subsidiary's financial results.